Katheryne Richardson

Katheryne Richardson is a managing director in BRG’s Healthcare practice and has over twenty-five years of experience including pharmacy practice, strategic consulting, drug pricing and policy analytics, and pharmaceutical industry executive leadership. She has specific expertise in the strategy, operations, and analytics of programs such as the 340B Drug Pricing Program and the Inflation Reduction Act (IRA). She specializes in leveraging technology enablement to support strategic consulting for clients across the healthcare continuum, including pharmaceutical manufacturers and others. She focuses on creating strategic insights and opportunities that expand clients’ capabilities to understand, deliver, and optimize their performance in the dynamic drug–pricing and policy landscape.